论文部分内容阅读
复习相关文献 ,对甲状腺Hurthle细胞肿瘤作综述性报道如下 :(1 )Hurthle细胞肿瘤与滤泡状肿瘤在分子水平存在很大差异 ;(2 )临床与细胞形态学标准不能准确区分Hurthle细胞肿瘤良恶性及预测肿瘤复发 ;(3)Hurthle细胞腺瘤应采取腺叶加峡部切除术 ,腺癌宜行全甲状腺切除 ,存在转移淋巴结时附加颈淋巴结清除术 ,对所有病人应进行长期随访 ;(4)Hurthle细胞肿瘤应列为一种独立的病理类型 ;(5)区分腺瘤与腺癌的标准需进一步明确以指导临床治疗 ;(6)目前对Hurthle细胞肿瘤病人宜采取个体化原则治疗。
Review of the relevant literature, the thyroid Hurthle cell tumor for the review reported as follows: (1) Hurthle cell tumor and follicular tumors at the molecular level there is a big difference; (2) clinical and cell morphology criteria can not accurately distinguish Hurthle cell tumor Malignant and predict tumor recurrence; (3) adenocarcinoma and isthmus resection should be taken in Hurthle cell adenocarcinoma, total thyroidectomy should be performed in adenocarcinoma, cervical lymph node dissection in the presence of metastatic lymph nodes, and long-term follow-up in all patients; ) Hurthle cell tumors should be classified as an independent pathological type; (5) the criteria for distinguishing between adenoma and adenocarcinoma need to be further clarified to guide clinical treatment; and (6) individualized principles of treatment for Hurthle cell tumor patients are currently advised.